Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results

Mahlangu, J; Lamas, JL; Morales, JC; Malan, DR; Teeter, J; Charnigo, RJ; Hwang, E; Arkin, S

Mahlangu, J (通讯作者)，Univ Witwatersrand, Fac Hlth Sci, 7 York Rd, ZA-2194 Johannesburg, South Africa.;Mahlangu, J (通讯作者)，Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, 7 York Rd, ZA-2194 Johannesburg, South Africa.

BRITISH JOURNAL OF HAEMATOLOGY, 2023; 200 (2): 240

Abstract

Marstacimab, an investigational human monoclonal antibody targeting tissue factor pathway inhibitor, demonstrated safety and efficacy in preventing bl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索